[ad_1]
Original title: Renfu Pharmaceutical Group Co., Ltd. Announcement of Pledging and Reconfirmation of Certain Controlling Shareholder Actions
Code: 600079 Abbreviation: Renfu Medicine Number: Lin 2020-128
Special note
Important reminder of the content
● Renfu Pharmaceutical Group Co., Ltd. (hereinafter “Renfu Medicine” or “Company”), the controlling shareholder of Wuhan Modern Technology Industry Group Co., Ltd. (hereinafter “Modern Science and Technology”) holds 396,079 .114 shares of the company, representing the total share capital of the company 25.65%. After the release of the promise and the new promise, the number of shares of the promised company in modern technology is 304,741,819 (including this time), equal to 76.94% of the total shares of the company held by it and 19.74% of the total share capital of the company.
The company received a notice from its controlling shareholder, Modern Technology on November 20, 2020, and learned that it has managed some of the company’s unrestricted tradable shares in China Securities Depository and Clearing Co., Ltd. for the registration of the release of the commitment and new commitment, The specific issues are as follows:
1. Release of pledge on shares of listed companies
1. The basic situation of the release of the pledge of shares
On the same day, Modern Technology renewed the shares released by the pledge to the Optics Valley Branch of Wuhan Rural Commercial Bank Co., Ltd. See below for details.
2. Pledge of shares of listed companies
1. The basic situation of this equity commitment
2. Pledged shares are not used as collateral or other collateral for offsetting performance of major asset restructuring and other issues.
3. Shares cumulatively guaranteed by shareholders
As of the date of the announcement, Modern Technology’s accumulated pledges are as follows:
3. The pledge of shares by controlling shareholders of listed companies
1. Pledging shares of the controlling shareholder which will expire in the next six months and one year respectively
Modern Technology’s pledged number of shares due over the next six months is 29,174,223 shares, equal to 7.37% of its holdings and 1.89% of the company’s total equity, corresponding to a financial balance of 508 million yuan; expiring within the next year (excluding expiration within six months) The shares pledged are 197,807,596, representing 49.94% of its holdings and 12.81% of the company’s total capital, corresponding to a financial balance of 2.58 billion RMB. The primary purpose of Modern Technology’s handling of the pledge and new stock commitment is to meet its business development needs. Loan funds are mainly used to supplement working capital. Sources of redemption funds include operating income, operating income, investment income, etc. At present, modern technology has stable operations, good credit status and the ability to execute contracts. So far, there is no risk of debt repayment.
2. As of the date of disclosure of this announcement, there is no situation in which Modern Technology has infringed the interests of listed companies by taking out non-operating capital, illegal guarantees and related transactions.
3. The impact of the pledge of the controlling shareholders on listed companies
(1) The commitment will not have a material impact on the company’s core business, financing credit and financing costs and sustainable operational capabilities.
(2) This commitment will not affect the composition of the company’s board of directors, the relationship between the controlling shareholder and the company in terms of property rights, business, assets and personnel, and will not cause changes in the effective control rights of the company. society.
(3) As of the date of this announcement, the company’s controlling shareholder, Dangdai Technology, has no performance compensation obligations that must be performed.
4. Risk response measures
Modern technology is committed to providing guarantees for financing and no major risks have been discovered in terms of the ability to repay the funds owed. Modern Technology’s credit status is good, with the ability to repay funds, there is no risk of liquidation or forced liquidation, and it will not cause major changes in the company’s share structure; if there is a liquidation risk, Modern Technology will take measures that include but are not limited to early repayment Measures such as grants, additional commitments, etc. They should respond to the above risks and promptly notify the listed company.
In the event of risks or major changes in the above matters, the company will disclose relevant information in a timely manner in accordance with relevant regulations. Special announcement.
Renfu Pharmaceutical Group Co., Ltd.
Board of Directors
November 21 of the second year
Source link
